ArticleNature communications2019
The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer.
Katherine A Michaelis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
117 papers cite itlatest 60 shown
this paperpooled itcites it